NDC 17856-0353-2 - Pharbetol Regular strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0353
- Requested NDC
- 17856-0353-2
- Package NDCs from labels
- 17856-0353-2, 17856-0353-1, 17856-0353-4, 17856-0353-3
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-06-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PHARBEST IBUPROFEN Drug Facts | ATLANTIC BIOLOGICALS CORP. | 2025-06-05 | HUMAN OTC DRUG LABEL |
| Pharbetol Regular strength - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2024-04-30 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0353-1 | 2024-06-26 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
| 17856-0353-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0353-1 | PharbetolRegular strength | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 3 | |
| 17856-0353-2 | PharbetolRegular strength | 1 in 1 POUCH | TABLET | 1 | 3 | |
| 17856-0353-4 | PharbetolRegular strength | 24 in 1 BOTTLE | TABLET | 24 | 3 | |
| 17856-0353-3 | PharbetolRegular strength | 28 in 1 BOTTLE | TABLET | 28 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, Legacy NDC, 3 package rows | 20240627_05a91d24-b498-4ba2-a275-68b871cf62d2.zip |
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20240508_bd26081c-e81e-42e8-b3da-2813863a51df.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| foster and thrive pain reliever | ACETAMINOPHEN | Strategic Sourcing Services LLC | 23780dab-91d8-434f-9342-f5f1ba0a3c0a | 2025-04-15 | Warnings | 362O9ITL9D |
| Premsyn pms Premenstrual Pain Relief | ACETAMINOPHEN AND PAMABROM AND PYRILAMINE MALEATE | Focus Consumer Healthcare, LLC | 5b6f6260-69ae-cfeb-e053-2a91aa0a6b49 | 2025-04-14 | Warnings | M013 362O9ITL9D |
| BackAid Max | ACETAMINOPHEN, PAMABROM | Kobayashi Healthcare International, Inc. | fb9a5647-b7c9-4820-b148-91060e34cb83 | 2025-04-14 | Warnings | M013 362O9ITL9D |
| Butalbital, Acetaminophen and Caffeine | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | Aurolife Pharma, LLC | f9fde75d-7def-48fc-a2b0-727f677f6001 | 2025-04-14 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| RIGHT REMEDIES LOW DOSE Aspirin 81mg | ASPIRIN | Strive Pharmaceuticals Inc. | 322c0e50-cf75-51ab-e063-6294a90a9235 | 2025-04-14 | Warnings | M013 |
| Bayer Aspirin Regimen Chewable Low Dose Aspirin Orange | ASPIRIN | Bayer HealthCare LLC. | 0c6ae05f-760f-34d1-e054-00144ff88e88 | 2025-04-11 | Warnings | M013 |
| Arthriten Inflammatory Pain Formula | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Kobayashi Healthcare International, Inc | c280ca89-4fb5-4050-90ee-d706a550a1ef | 2025-04-11 | Warnings | M013 362O9ITL9D |
| Midol Complete | ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE | Bayer HealthCare LLC. | ce9e6acb-a38b-4c9b-a7e8-3e1c2a49a324 | 2025-04-10 | Warnings | 362O9ITL9D |
| Bayer Back and Body Extra Strength | ASPIRIN,CAFFEINE | Bayer HealthCare LLC. | 0c77c484-6caf-12ca-e054-00144ff88e88 | 2025-04-10 | Warnings | M013 |
| Anua Zero-Cast Moisturizing Finish Sunscreen SPF 50 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | ENGLEWOOD LAB, INC. | edf07b7f-46fb-4915-b2ea-83d852617f60 | 2025-04-10 | Warnings | M |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Redpharm drug | 1535f903-8bd0-c09e-e063-6294a90a4d4d | 2025-04-09 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Acetaminophen and Codeine | ACETAMINOPHEN AND CODEINE | RedPharm Drug, Inc. | a35b4ba3-43c0-73c8-e053-2a95a90af5b5 | 2025-04-09 | Boxed warning, Warnings | 362O9ITL9D |
| Adult Low Dose Enteric Coated Aspirin | ASPIRIN | NuCare Pharmaceuticals, Inc. | 324937c3-c558-bc79-e063-6294a90acc8e | 2025-04-08 | Warnings | M013 |
| Foster and Thrive Pain Reliever | ACETAMINOPHEN | Strategic Sourcing Services LLC | 0a7d82f8-7615-4cef-b245-94b186f3c8fa | 2025-04-07 | Warnings | 362O9ITL9D |
| Oxycodone and Acetaminophen | OXYCODONE AND ACETAMINOPHEN | Direct_Rx | e4e27022-581e-ba8c-e053-2a95a90a1ae4 | 2025-04-07 | Warnings, Adverse reactions | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | Gland Pharma Limited | db5d4cf8-762a-4111-971e-91c704bc3643 | 2025-04-04 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN 500MG | CVS Pharmacy, Inc. | 1fde6487-6682-99a3-e063-6294a90a3670 | 2025-04-04 | Warnings | M013 362O9ITL9D |
| Acetaminophen 250 mg and Ibuprofen 125 mg | ACETAMINOPHEN AND IBUPROFEN | Dr. Reddy's Labortories Inc | 3e65c8a3-498e-1a2a-bb76-18e28ae2c73c | 2025-04-04 | Warnings | 362O9ITL9D |
| Nighttime Ultra Concentrated Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE SOFTGELS | WALGREENS | 2be0a699-e6ad-ef56-e063-6394a90aaca5 | 2025-04-03 | Warnings | 362O9ITL9D |
| Acetaminophen and Codeine Phosphate | ACETAMINOPHEN AND CODEINE PHOSPHATE | NuCare Pharmaceuticals, Inc. | 31d24067-3c25-0f1a-e063-6394a90a9f1d | 2025-04-02 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.